<DOC>
	<DOCNO>NCT00034892</DOCNO>
	<brief_summary>The purpose study compare effectiveness , tolerability , efficacy currently available atypical antipsychotic drug olanzapine ( 2.5-20 mg/day ) , quetiapine ( 100-800 mg/day ) risperidone ( 0.5-4 mg/day ) patient schizophrenia , schizophreniform disorder , schizoaffective disorder experience first psychotic episode .</brief_summary>
	<brief_title>CAFE Comparison Atypicals First Episode Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Patients must meet criterion schizophreniform disorder , schizophrenia , schizoaffective disorder psychotic symptom last 160 month Psychotic symptom must persist least one month , thn 5 year ( 60 month ) Patients must previous history drug treatment ( great total 16 week ) antipsychotic Patients history psychotic disorder recovery period least 3 month Female patient pregnant nursing Patients know history mental retardation</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>